Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: Implications for adoptive immunotherapy

Journal of Immunology

Volumn 168, Issue 10, 2002, Pages 4864-4870

  Derre, Laurent ^a   Corvaisier, Murielle ^a   Pandolfino, Marie Christine ^a   Diez, Elisabeth ^a   Jotereau, Francine ^a   Gervois, Nadine ^a  

^a Inst Natl de la Recherche   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; T LYMPHOCYTE RECEPTOR; TUMOR PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; MELANOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0037094030     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.10.4864     Document Type: Article

References (35)

1. Natural killer cell activation and inhibition by receptors for MHC class 1
2. + T cells
3. Regulation of T cell function by NK cell receptors for classical MHC class I molecules
4. Regulation of immune responses through inhibitory receptors
5. Association of DAP12 with activating CD94/NKG2C NK cell receptors
6. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
7. Structure of CD94 reveals a novel C-type lectin fold: Implications for the NK cell-associated CD94/NKG2 receptors
8. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene
9. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
10. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
11. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
12. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
13. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
14. Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals
15. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
16. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen-specific CTL
17. Inhibition of antigen-induced T cell response and Ab-induced NK cell cytotoxicity by NKG2A: Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases
18. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: Differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity
19. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients
20. In vivo expression of natural killer cell inhibitory, receptors by human melanoma-specific cytolytic T lymphocytes
21. + T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: Evidence for a role of KIR in the control of peripheral tolerance
22. Functional inhibitory, receptors expressed by a cutaneous T cell lymphoma-specific cytolytic clonal T cell population
23. Transforming growth factor-β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes
24. + T Iymphocytes
25. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding
26. Phenotypic analysis of antigen-specific T lymphocytes
27. Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
28. High avidity melanomareactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells
29. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3
30. + T lymphocytes from healthy donors and multiple sclerosis patients
31. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells
32. IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation
33. Receptors for HLA class-I molecules in human natural killer cells
34. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
35. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses